Addressing the Accuracy Crisis in Clinical Trial Imaging
A recent panel podcast on The Imaging Accuracy Crisis in Clinical Trials brought to light critical issues and innovative...
Gilead Reveals Remarkable Findings in HIV Prevention Trial: Encouraging News for a Devastating Disease
Gilead Sciences has reported promising data from its Phase 3 PURPOSE 2 trial, demonstrating the efficacy and safety of...
Airsupra Reduces Severe Asthma Attacks: A Game-Changer for Patients
A clinical trial (BATURA) has shown the efficacy of AstraZenaca’s AIRSUPRA (albuterol/budesonide) in reducing the risk of severe asthma...
Embracing Technology in Clinical Operations: A Conversation with Bonne Adams of Inhibrx
We had the pleasure of speaking with Bonne Adams, Vice President of Operations at Inhibrx Therapeutics, at the Veeva...
New HPV Vaccine Trial Gives Hope to Cancer Patients
TheraVectys, a biotechnology company specializing in lentiviral vector-based vaccines and immunotherapies, has begun enrolling patients in a Phase I/IIa...
Summit Therapeutics: Remarkable Results in Phase III HARMONI Trial for Lung Cancer
Summit Therapeutics has completed enrollment in the multi-regional Phase III HARMONi trial, evaluating ivonescimab in combination with chemotherapy for...
ACTICOR Biotech Secures Receivership Extension for Glenzocimab Development
The Paris Commercial Court has granted an extension of receivership proceedings for ACTICOR Biotech, a biopharmaceutical company focused on...
U.S. FDA Approves Opdivo® for Resectable Non-Small Cell Lung Cancer
The U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) for treating adults with resectable non-small cell lung...
Humanetics Corp. Wows at 2024 DoD Scientific Meeting: A Testimony to Enduring Innovation
Humanetics Corporation presented updates on the progress of BIO 300, an orally administered drug designed to prevent radiation toxicity...
Allele-Selective Therapies for Rare Genetic Disorders: Regulatory Challenges and Solutions
Recent advances in genetic sequencing have identified an increasing number of rare heterozygous toxic gain-of-function (TGOF) mutations. These mutations...